Promoter pledge creation at Ajanta Pharma for NCD issuance (revised)
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts more than Nifty Midcap 150 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoters of Ajanta Pharma, including Aayush Agrawal Trust, Aayush Agrawal individually, and Gabs Investments, have pledged 66.33 lakh shares (around 5.31 percent of capital) as security for non-convertible debenture issuance. NCDs are held by CTL Trusteeship for 360 ONE funds and 360 ONE Prime Ltd. This is a revised filing correcting the name of the entity holding the encumbrance. Post this, Aayush Agrawal Trust has 1.35 crore shares (10.83 percent) pledged, about 95.8 percent of its holding.
Promoters raising debt via NCDs using shares as collateral. Aayush Trust is about 95 percent pledged, showing high leverage for that entity.